Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Maplight Therapeutics
Maplight Therapeutics
A brain-focused biotech raises $225M to develop drugs for schizophrenia, Parkinson’s
BioPharma Dive
Mon, 10/30/23 - 08:21 pm
Maplight Therapeutics
funding
schizophrenia
Maplight concludes Phase I trial of schizophrenia and dyskinesia therapy
Clinical Trials Arena
Fri, 08/19/22 - 10:38 am
Maplight Therapeutics
clinical trials
ML-007
schizophrenia
dyskinesia